Sepia Melanin for the Local Deactivation of Matrix Metalloproteinases

Seth D Edwards1, Zhen Tian1, Young Jo Kim1

  • 1Department of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, New Hampshire 03824, United States.

ACS Macro Letters
|April 15, 2025
PubMed

Insights

Sepia melanin deactivates matrix metalloproteinases (MMPs) by chelating zinc ions, offering a novel approach to managing chronic wounds. This natural biopigment shows potential for improving wound healing outcomes by targeting MMPs involved in nonhealing environments.

Area of Science:

  • Biochemistry
  • Biomaterials Science
  • Wound Healing Research

Background:

  • Matrix metalloproteinases (MMPs) are crucial for tissue remodeling but their chronic overexpression contributes to nonhealing wounds.
  • Current treatments aim to deactivate MMPs to improve chronic wound healing outcomes.
  • Natural compounds are being investigated for their therapeutic potential in wound management.

Purpose of the Study:

  • To investigate sepia melanin's capacity to deactivate matrix metalloproteinases (MMPs).
  • To explore the mechanism of MMP deactivation by melanin through zinc ion chelation.
  • To evaluate melanin's efficacy in an in vitro model simulating chronic wound conditions.

Main Methods:

  • Chelation assays to assess melanin's binding affinity for zinc ions.
  • Enzyme activity assays to measure the deactivation of MMP-1, MMP-2, and MMP-9 by melanin.
  • In vitro tissue assays using a simulated nonhealing wound environment to demonstrate functional application.

Main Results:

  • Sepia melanin effectively chelates zinc ions, a key step in MMP deactivation.
  • Melanin demonstrated significant deactivation of MMP-1, MMP-2, and MMP-9, enzymes implicated in chronic wounds.
  • In vitro assays confirmed melanin's potential application in promoting wound healing within a chronic wound milieu.

Conclusions:

  • Sepia melanin can deactivate MMPs by chelating zinc ions, representing a novel therapeutic strategy.
  • This study is the first to demonstrate melanin's utility in deactivating MMPs for wound healing applications.
  • Melanin shows promise as a natural, biocompatible agent for managing chronic nonhealing wounds.